FDA Inspection 1330484 — SpectraWAVE, Inc.

SpectraWAVE, Inc. — FEI 3017654247

The FDA completed an inspection of SpectraWAVE, Inc. on Aug 11, 2026 in Bedford, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 11, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Bedford, MA (United States)

Citations

IDCFRDescription
23138ISO 13485:2016 Clause 7.4.1Procedures for purchasing process not documented
23214ISO 13485:2016 Clause 8.2.2Complaint handling procedures not documented
23258ISO 13485:2016 Clause 8.5.2Corrective action procedures not documented
570021 CFR 1002.10Failure to submit, distinct marking
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.